Overview
GenesisCare, Newcastle offers access to evidence-based care, including radiation therapy and allied health support.
GenesisCare, Newcastle aims to offer access to holistic, personalised care for patients, with services including radiation therapy and allied health support. Care should be available when and where the patient needs it most, and it should be designed to give patients the best life outcomes possible.
We are situated on the campus of Lake Macquarie Private Hospital and form a part of the comprehensive Hunter Cancer Centre.
We aim to offer access to:
- Rapid access to consultation and treatment delivered using modern radiation therapy technology
- Personalised treatment plan for every patient
- Designated free parking
Specialist oncology consultation is available in Port Stephens
Consulting specialists have the support of Ramsay Health Care’s local network of facilities located at Lake Macquarie Private Hospital and Warners Bay Private Hospital, offering patients further choice, convenience and the opportunity for easier access to health care.
Our treatments and services
Radiation Oncology
Radiation therapy uses high energy X-rays or other particles to treat cancer and can be used at all stages. Radiation therapy techniques can include: External Beam Radiation Therapy (EBRT), Deep Inspiration Breath Hold (DIBH) for left-sided breast treatment, Intensity Modulated Radiation Therapy (IMRT), Volumetric Modulated Arc Therapy (VMAT), Stereotactic Radiosurgery (SRS),
Stereotactic Ablative Body Radiotherapy (SABR), Brachytherapy, and specialised non-surgical treatment for skin cancer and some benign conditions.
Clinical trials
At GenesisCare, we challenge ourselves every day to help find new and better ways to provide high-quality care, and we aim to deliver the best possible outcomes for our patients wherever we can. Our Newcastle team may be able to offer you access to the GenesisCare global network of clinical trials. For further information on clinical trial participation, please speak with your treating doctor.
Allied Health Services
At GenesisCare, Newcastle we offer you access to a range of Allied health services, all tailored to support your needs. One of your treatment team will discuss the most suitable options with you. Support services offered may include:
- Exercise Physiology - access via Ethos Health
- Psychologist
- Palliative Care
- Speech Pathologist
- Dietitian
Exercise Medicine
Considerable research and clinical evidence has established that exercise may be beneficial for people with cancer; however, there is no one-size-fits-all
approach.1,2 Every person’s circumstances are unique and these should be taken into account. Tailored exercise programs designed by an exercise professional that include both aerobic and resistance training activities have been shown to provide benefits.3 To learn more about incorporating exercise during your cancer journey, please speak with your doctor and treatment team.
Doctors
Dr Anne Capp
BMedSci, MBBS, FRANZCR, FRCR, M.Med (ClinEpi)
Radiation Oncologist
Newcastle (Oncology) +1
Dr Eric Wegener
FRANZCR, MBBS, BMedSci(Hons), PGDip Surg Anat
Radiation Oncologist
Maitland (Oncology) +1
Professor Jarad Martin
MBChB BSc PhD DMed, FRANZCR GAustMS
Radiation Oncologist
Maitland (Oncology) +1
Dr Matt Mason
BMedSci(Hons), BMBS, MRCP(UK), FRCR, FRANZCR
Radiation Oncologist
Newcastle (Oncology) +1
Dr Philippa Ell
BAppSc(MRS)NucMed, MBBS, GradCertClinEpi, FRANZCR
Radiation Oncologist
Maitland (Oncology) +1
- Campbell KL, Winters-Stone KM, Wiskemann J, et al. Exercise guidelines for cancer survivors: Consensus statement from international multidisciplinary roundtable. Med Sci Sports Exerc 2019;51(11):2375–2390.
- Hayes SC, Newton RU, Spence RR, et al. The Exercise and Sports Science Australia position statement: Exercise medicine in cancer management. J Sci Med Sport 2019;22(11):1175–1199.
- Buffart LM, Kalter J, Sweegers MG, et al. Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs. Cancer Treat Rev 2017;52:91–104.